SCHEMBL25193451

SCHEMBL25193451

NCc1ccc(Nc2ccc(F)c(N3CCCC3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNQ2 O43526 1/20 0.38
▸ P2RX3 P56373 4/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HTT P42858 2/20 0.36
▸ PRMT6 Q96LA8 1/20 0.36
▸ CSF1R P07333 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ LOXL2 Q9Y4K0 1/20 0.34
▸ SOS1 Q07889 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ ACP1 P24666 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25190452 0.99 ALDH1A1 (0.38) KCNQ2P2RX3ALDH1A1KDM4EMEN1
SCHEMBL13736051 0.83 ALDH1A1 (0.42) KCNQ2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL25190301 0.80 KMT2A (0.39) ALDH1A1KDM4EMEN1KMT2AGFER
SCHEMBL25201540 0.79 S1PR1 (0.42) —
SCHEMBL25190342 0.77 MAPT (0.47) ALDH1A1KDM4EMEN1KMT2AALOX15
SCHEMBL25190432 0.75 MAPT (0.47) ALDH1A1KDM4EMEN1KMT2AALOX15
SCHEMBL4024455 0.73 ALDH1A1 (0.51) KCNQ2ALDH1A1MEN1KMT2AHPGD
SCHEMBL4027973 0.72 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHPGDGFER
SCHEMBL4029065 0.72 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHPGDGFER
SCHEMBL4023577 0.72 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHPGDGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 KCNQ2 2804/4885P2RX3 3041/4885ALDH1A1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback